Securities code: 688277 securities abbreviation: Tinavi Medical Technologies Co.Ltd(688277) Announcement No.: 2021-072 Tinavi Medical Technologies Co.Ltd(688277)
Suggestive announcement on the disclosure of the plan for issuing A-Shares to specific objects in 2021 (Revised Draft)
The board of directors and all directors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear legal liabilities for the authenticity, accuracy and integrity of its contents according to law. Tinavi Medical Technologies Co.Ltd(688277) (hereinafter referred to as “the company”) deliberated and adopted the proposal on adjusting the company’s plan for issuing A-Shares to specific objects in 2021 and the proposal on
<公司 2021年度向特定对象发行 A 股股票预案（修订稿）>
The company’s proposal on issuing A-Shares to specific objects in 2021 has been revised.
The Tinavi Medical Technologies Co.Ltd(688277) 2021 plan for issuing A-Shares to specific objects (Revised Version) and other documents have been disclosed on the website of Shanghai Stock Exchange (www.sse. Com.. CN). Please pay attention to the majority of investors.
The disclosure of the revised company’s plan for issuing A-Shares to specific objects in 2021 does not represent the substantive judgment, confirmation or approval of the approval and registration departments on the matters related to the issuance. The effectiveness and completion of the matters related to the issuance described in the revised plan need to be reviewed by Shanghai Stock exchange and registered with China Securities Regulatory Commission. Please pay attention to investment risks.
It is hereby announced.
Tinavi Medical Technologies Co.Ltd(688277) board of directors December 24, 2021
